Effect of an α-glucosidase inhibitor on glomerular basement membrane anionic sites in streptozotocin induced mildly diabetic rats

Diabetes Research and Clinical Practice

Volumn 37, Issue 2, 1997, Pages 91-99

  Sato, Hiroko ^a,b   Shiina, Noriko ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

glucosidase inhibitor; Anionic sites; Nephropathy; Streptozotocin; Urine albumin

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFECT; GLOMERULUS BASEMENT MEMBRANE; KIDNEY FUNCTION; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PROTEINURIA; STREPTOZOCIN DIABETES;

ACARBOSE; ALBUMINURIA; ALPHA-GLUCOSIDASES; ANIMALS; ANIONS; BASEMENT MEMBRANE; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; FRUCTOSAMINE; KIDNEY GLOMERULUS; MALE; RATS; RATS, WISTAR; TRIGLYCERIDES; TRISACCHARIDES;

EID: 0030788878     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00054-5     Document Type: Article

References (30)

1. H.C. Knowles, Magnitude of the renal problem in diabetes, Kidney Int. 6 (1974) 2-7.
2. C.E. Mogensen, Microalbuminuria and incipient diabetic nephropathy, Lancet 1 (1983) 1175-1178.
3. E.R. Mathiesen, B. Oxenboll, K. Johansenl, et al., Incipient nephropathy in type 1 (insulin-dependent) diabetes, Diabetologia 26 (1984) 406-410.
4. W. Caspary, Sucrose malabsorption in man after ingestion of a glucoside hydrolase inhibitor, Lancet 1 (1978) 1231-1233.
5. W. Puls, U. Keup, P. Krause, Pharmacology of a glucosidase inhibitor, Front Hormone Res. 72 (1980) 35-247.
6. S. Lee, S. Bustamante, O. Koldovsky, The effect of a glucosidase inhibition on intestinal disaccharidase activity in normal and diabetic mice, Metabolism 32 (1983) 793-799.
7. M. Hanefeld, S. Fisher, J. Schulze, et al., Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone, Diabetes Care 14 (1991) 732-737.
8. M. Cohen, J. Vasselli, R. Neuman, J. Witt, Treatment with acarbose, an α-glucosidase inhibitior, reduces increased albumin excretion in streptozotocin-diabetic rats, Gen. Pharmacol. 26 (1995) 1355-1361.
9. G. Yoshino, M. Matsushita, M. Morita, et al., Effect of mild diabetes and dietary fructose on very-low-density lipoprotein triglyceride turnover in rats, Metabolism 41 (1992) 236-240.
10. Y. Oshima, S. Isogai, K. Mogami, et al., Protective effect of heparin on renal glomerular anionic sites of streptozotocin-injected rats, Diab. Res. Clin. Prac. (1994) 83-89.
11. S.A. Glanz, Primer of Biostatistics, McGraw-Hill, New York, 1981.
12. C.E. Mogensen, Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy, Br. Med. J. 285 (1982) 655-689.
13. H.-H. Parving, A.R. Andersen, U.M. Smidt, P.A. Svendsen, Early and aggressive ant/hypertensive treatment reduces the rate of decline in kidney function in diabetic nephropathy, Lancet 1 (1983) 1175-1179.
14. J. Rosenstock, P. Raskin, Early diabetic nephropathy, assessment and potential therapeutic investigations, Diabetes Care 9 (1986) 529-545.
15. T. Hostetter, J. Troy, B. Brenner, Glomerular hemodynamics in experimental diabetes mellitus, Kidney Int. 19 (1981) 410-415.
16. E. Yaoita, K. Oguri, E. Okayama, et al., Isolation and characterization of proteoglycans synthesized by cultured mesangial cells, J. Biol. Chem. 265 (1990) 522-531.
17. K. Mogami, Preventive effect of insulin or heparin on development of nephropathy in streptozotocin-induced diabetic rats, J. Jpn. Diab. Soc. 34 (1991) 105-111.
18. S. Isogai, T. Inokuchi, K. Mogami, et al., Preventive effects of insulin on the enlagement of pore size on glomerular basement membrane in diabetic rats, Diabetes 45 (Suppl. 2) (1996) 274A.
19. T. Al-Shebeb, J.I.R. Frohlich, A.B. Magil, Glomerular disease in hypercholesterolemic guinea pigs: A pathogenetic study, Kidney Int. 33 (1988) 498-507.
20. H. Grone, A. Walli, E. Grone, et al., Induction of glomerular sclerosis by dietary lipids: A functional and morphologic study in the rat, Lab. Invest. 60 (1989) 433-445.
21. B.L. Kasiske, M.P. O'Donnell, P.G. Schmitz, et al., Renal injury of diet-induced hypercholesterolemiain rats, Kidney Int. 37 (1990) 880-891.
22. J.R. Diamond, M.J. Karnovsky, Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation, Kidney Int. 32 (1987) 671-677.
23. B.L. Kasiske, M.P. O'Donnell, M.P. Clearly, W.F. Keane, Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats, Kidney Int. 33 (1988) 667-672.
24. K.P. Harris, M.L. Purkerson, J. Yates, S. Klahr, Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome, Am. J. Kidney Dis. 15 (1990) 16-26.
25. B.D. Rovin, L.C. Tan, LDL stimulates mesangial fibronectin production and chemoattractant expression, Kidney Int. 43 (1993) 218-225.
26. S.B. Kim, S.A. Kang, Y.J. Cho, et al., Effect of low density lipoprotein on type IV collagen production by cultured rat mesangial cells, Nephron 67 (1994) 327-333.
27. G. Yoshino, M. Matsushita, E. Maeda et al, Effect of long-term insulin deficiency and insulin treatment on the composition of triglyceride-rich lipoproteins and triglyceride turnover in rats, Atherosclerosis 92 (1992) 243-250.
28. M. Cohen, H. Klepser, Y. Wu, Effect of alpha-glucosidase inhibition on the non enzymatic glycation of glomerular basement membrane, Gen. Pharmacol. 22 (1981) 515-519.
29. S. Lee, The effect of chronic alpha-glycosidase inhibition on diabetic nephropathy in the db/db mouse, Diabetes 31 (1982) 249-254.
30. K. Ohe, Change in anionic sites on glomerular basement membrane following mesangiolysis - observation in incipient anti-rat Thy1 nephritis, Jpn. J. Nephrol. 35 (1993) 1007-1014.